Abstract: Compositions (feeding deterrent/repellent for Halyomorpha halys) containing at least two compounds selected from tridecane, E-2-decenal, isolongifolanone, isolongifolenone, and at least one isolongifolenone analog having the following formula: wherein R1 is hydrogen, an oxygen, a C1-10 alcohol, aldehyde, alkyl, ether, or esters of said alcohol with a C1-10 saturated or unsaturated, straight or branched acid and R2 is hydrogen, an oxygen, a C1-10 alcohol, aldehyde, alkyl, ether, or esters of said alcohol with a C1-10 saturated or unsaturated, straight or branched acid; optionally there is a double bond between carbons 5 and 6 and R2 is hydrogen; and optionally a carrier or carrier material. Also methods for deterring feeding/repelling Halyomorpha halys involving treating an object or area with a Halyomorpha halys deterring feeding/repelling effective amount of at least one compound selected from the above compounds.

Abstract: Medicinal compositions, and devices, methods and systems which use the compositions, comprising a propellant and at least one medicinally active compound. The propellant comprises at least one fluoroolefin having at least two but less than seven carbon atoms.

Abstract: Provided is a method for preparing nanocapsules having a liquid lipid core and a solid shell and charged in their lipid core with at least one hydrophilic active agent involving combining microemulsions where the active agent remains in the hydrophilic phase of a first microemulsion and chill-hardening the mixture to obtain the nanocapsules charged with the hydrophilic active agent. The nanocapsules comprise the lipid core which is liquid at room temperature and the nanocapsules are encapsulated in a film which is solid at room temperature.

Abstract: The invention provides a biocompatible article having a surface comprising collagen fibrils attached to said surface via one or more linker molecules, wherein each of said collagen fibrils is attached to at least one of said one or more linker molecules at a proximal end of the fibril, and wherein each of said collagen fibril has a proximal portion extending from said proximal end to a point P along said fibril, wherein, for a majority of said fibrils, each fibril at said point P is oriented so as to form an angle ?P in the range of 0° to 45° to the surface normal N at the point of attachment of said fibril to said surface. The collagen fibril-coated surface has improved biocompatibility and is useful in a medical implant intended for implantation into soft tissue or bone tissue.

Abstract: The invention describes a multistage process, for producing particles with an average particle size from 50 nm to 1000 nm in a very effective and gentle manner, wherein the solid substance (active substance) is dissolved in a solvent, this liquid containing the solid substance (active substance) in dissolved form is then frozen very rapidly, the solvent/solvents used are optionally removed from the frozen matrix obtained in a (freeze-)drying process (lyophilization) or the frozen matrix is further processed directly, the solid matrix (frozen or lyophilized) is dispersed in an external phase, a liquid medium, which can be water, a mixture of water with water-miscible liquids or a non-aqueous liquid, and the resulting dispersion is then immediately exposed to high shear and/or cavitation forces, and the forces applied result in stabilization or comminution of the resulting particles in the nanometer range.

Abstract: The invention pertains to a biocompatible composition, suitable for use in soft or hard tissue augmentation, wherein the composition is an aqueous suspension containing a carrier fraction of ceramic particles of less than 15 ?m and an augmentation fraction of ceramic particles of at least 20 ?m. The ceramics typically include calcium phosphate. The composition is a may be used in soft tissue repair as well as hard bone replacement. It advantageously avoids the need for foreign body materials which are conventionally applied to stabilize augmentation suspensions.

Abstract: A method and device for local delivery of water-soluble or water-insoluble therapeutic agents to the surface of a normal or diseased body lumen is disclosed. An expandable structure of a medical disposable device, such as a balloon of a balloon catheter, is coated with an amphiphilic polymer coating comprising a therapeutic agent and an amphiphilic polymer or co-polymer. The medical disposable device is inserted into a body lumen, and expanded to contact the amphiphilic polymer coating against the body lumen. The total solubility of the polymer or co-polymer in vivo prevents any embolic hazard associated with the amphiphilic polymer coating.

Abstract: There is provided a granular material comprising (i) at least 50% by weight based on the weight of the granular material of solid water-insoluble mixed metal compound capable of binding phosphate of formula (I): MII1-xMIIIx(OH)2An-y.ZH2O (I) where MII is at least one of magnesium, calcium, lanthanum and cerium; MIII is at least iron(III); An- is at least one n-valent anion; x=?ny; 0<x?0.67, 0<y?1, and 0?z<10; (ii) from 3 to 12% by weight based on the weight of the granular material of non-chemically bound water, and (iii) no greater than 47% by weight based on the weight of the granular material of excipient.

Abstract: An oil and water gel composition is provided containing a polymer gel former of a polymer or copolymer of acrylic acid or acrylamide, a wax component having a melting point of at least 30° C. containing esters of pentaerythritol, dipentaerythritol and/or tripentaerythritol, and an oil component liquid at 25° C. and water.

Abstract: This invention relates to compositions and methods for hair bleaching. In particular, the invention concerns stabilized hair bleach products that contain at least one persulfate salt, and an oil gel. The composition of the present invention forms an emulsion where the oil and salt do not separate providing a consistent and stable hair bleach formulation.

Abstract: The present invention is directed to methods, compositions and articles comprising olfactory-active compositions. An article of the present invention comprises a structural component and an olfactory-active composition. The article may control the release, release rate or absorption of the olfactory-active composition. The article may be of various shapes and sizes. A method of use of an article comprises providing fragrance to an environment.

Abstract: Dry powder foundation formulations that include a sustained-release salicylic acid composition, an effective, buffering amount of one or more salicylate ions, and one or more of zinc and titanium oxides, and pigments or colorants, are disclosed. The formulations provide both acne treatment and prevention, and sunblock protection. The formulation can also include other sunblocking or sunscreen agents to prevent photoaging and sunburn, such as avobenzone, and 3-benzophenone, and other cosmetically-acceptable active agents and excipients.

Abstract: The bright pigment of the present invention contains a scaly substrate 10 and an outermost coating 20 that covers the scaly substrate 10, that is provided as an outermost layer, and that contains at least one member selected from the group consisting of hydroxyapatite and hydrocalumite. The bright pigment of the present invention may be further provided with an interference color coating that is disposed more towards the center than the outermost coating and that contains at least one metal oxide selected from the group consisting of titanium oxide and iron oxide. Moreover, the bright pigment of the present invention may be further provided with a silver-containing coating that is disposed more towards the center than the outermost coating and that contains silver and/or a silver alloy. The outermost coating may contain an anionic pigment.

Abstract: Fragrance leaches rapidly from capsules having shells made from cross linked gelatin into volatile silicone oils. Unfortunately such oils are much favored for anhydrous antiperspirant compositions. The rate and extent of leaching can be ameliorated greatly or nearly halted by employing as carrier oil, an ester oil or an ether oil, even in the presence of a significant fraction of volatile silicone oil. Consequently, the capability of antiperspirant compositions to generate detectable fragrance over an extended period after application to the skin is improved by employing ester or ether oil as all or part of the carrier liquid in which the antiperspirant is suspended.

Abstract: The invention relates to a composition comprising at least one aqueous polyurethane dispersion, at least one oil-soluble polar modified polymer, at least one alkoxylated fatty alcohol, and at least one polyamine compound having at least two amine groups.

Abstract: This invention is related to the use of polyurethane-based polymer as a drug delivery device to deliver biologically active risperidone at a constant rate for an extended period of time and methods of manufactures thereof. The device is very biocompatible and biostable, and is useful as an implant in patients (humans and animals) for the delivery of risperidone to tissues or organs.

Abstract: The present invention preferably provides for a method of forming and the resulting solid polymer gel composition comprising polyethylene imine and at least one hydrogen bonding polymer. The composition has a greater viscosity than either of the polyethylene imine or the hydrogen bonding polymer alone and is injectable immediately after mixing of the polyethylene imine and the at least one hydrogen bonding polymer. A method of tissue repair may include mixing about 9.25% (w/w) to about 13.65% (w/w) polyethylene imine and about 18.02% (w/w) to about 26.62% (w/w) polyvinyl alcohol to form an injectable composition; injecting the injectable composition into a cavity within a human body; and allowing the composition to solidify in situ. A kit may include a multi-barrel syringe at least one barrel is loaded with polyethylene imine and at least another barrel is loaded with at least one hydrogen bonding polymer.

Abstract: Fragrance leaches rapidly from capsules having shells made from cross linked gelatin into volatile silicone oils. Unfortunately such oils are much favored for anhydrous antiperspirant compositions. The rate and extent of leaching can be ameliorated greatly or nearly halted by employing as carrier oil, an ester oil or an ether oil, even in the presence of a significant fraction of volatile silicone oil. Consequently, the capability of antiperspirant compositions to generate detectable fragrance over an extended period after application to the skin is improved by employing ester or ether oil as all or part of the carrier liquid in which the antiperspirant is suspended.

Abstract: Disclosed are microcapsules and methods for preparing and using them, as well as methods for improving various properties of microcapsules like impermeability.

Abstract: The present disclosure generally relates to biocompatible polymers for coating or fabricating implantable medical devices and to implantable medical devices having the present biocompatible polymers. The disclosed biocompatible polymers exhibit superior biocompatibility and therefore minimize unwanted immune reaction from a patient into whom a medical device is implanted.